An individual must inform all healthcare providers of their allergies to ensure that they do not receive any medications that may cause an adverse reaction
Nakamura K, Sasaki T, Yamamoto S, Hayashi H, Ako S, Tanaka Y
Advancing genetic, biomarker- and neuroimaging guidance will help treatments to become more precise, indicating the right time in the disease course for the right patient, from preclinical asymptomatic to early prodromal and dementia stages
Significance during GLP-1 therapy: Both hypokalemia (low potassium) and hyperkalemia (high potassium) can have serious consequences
Using the Naranjo adverse drug reaction scale, researchers scored the association at 6 out of 13, indicating a "probable" relationship between the medication and the clot